🧪Current HHS-Certified Laboratories for Federal Drug Testing
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.
Learn More⚖️OSHA Grants Expansion of TUV Rheinland's NRTL Recognition
In this notice, OSHA announces the final decision to expand the scope of recognition for TUV Rheinland of North America, Inc., as a Nationally Recognized Testing Laboratory (NRTL).
Learn More⚖️HHS Issues New Drug Testing Guidelines for Federal Workplaces
The Department of Health and Human Services ("HHS" or "Department") herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in Federal workplace drug testing programs. The Department has revised the drug testing panels for both urine and oral fluid, and revised required nomenclature for laboratory and Medical Review Officer Reports.
Learn More🏥OSHA Terminates COVID-19 Rulemaking for Healthcare Settings
OSHA is terminating its COVID-19 rulemaking.
Learn More⚖️EPA Proposes Regulation for C.I. Pigment
The Environmental Protection Agency (EPA or Agency) is proposing to address the unreasonable risk of injury to human health presented by C.I. Pigment Violet 29 (CASRN 81-33-4, also known as PV29), under its conditions of use as documented in EPA's January 2021 Risk Evaluation for PV29 and the September 2022 Revised Risk Determination for PV29 prepared under TSCA. TSCA requires that EPA address by rule any unreasonable risk of injury to health or the environment identified in a TSCA risk evaluation and apply requirements to the extent necessary so the chemical no longer presents unreasonable risk. To address the identified unreasonable risk, EPA is proposing requirements to protect workers from the unreasonable risk of PV29 during manufacturing and processing, certain industrial and commercial uses of the chemical, and disposal, while also allowing for a reasonable transition period prior to enforcement of said requirements.
Learn More📋OSHA Requests Comments on Revised Safety Program Assessment Worksheet
OSHA solicits public comments concerning its request to extend OMB's approval of information collection requirements for OMB 1218- 0280, Expiration Date: June 30, 2025, regarding the Pilot Study for 3 years (i.e., to June 30, 2028).
Learn More🏢OSHA Seeks Comments on Worker Safety Information Collection Requirements
OSHA solicits public comments concerning its request to extend OMB's approval of information collection regarding the State Plans program and regulations for the development and enforcement of state occupational safety and health standards.
Learn More